Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

InVivo Therapeutics Holdings buy melinda

Start price
€32,134
31.07.17 / 50%
Target price
€40,590
19.12.17
Performance (%)
-53.52%
End price
€14,937
19.12.17
Summary
This prediction ended on 19.12.17 with a price of €14,937. The BUY prediction by melinda for InVivo Therapeutics Holdings performed very badly with a performance of -53.52%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
InVivo Therapeutics Holdings 1.899% 1.899% -69.907% -99.932%
iShares Core DAX® -0.383% 5.021% 16.188% 19.224%
iShares Nasdaq 100 1.248% 4.007% 36.579% 57.508%
iShares Nikkei 225® 0.525% -0.109% 12.378% 9.329%
iShares S&P 500 0.640% 3.649% 28.752% 47.932%

According to melinda what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Invivo Therapeutics diskutieren
Prediction Buy
Perf. (%) -53.52%
Target price 54.120
Change
Ends at 19.12.17
Prediction Buy
Perf. (%) -53.52%
Target price 54.120
Change
Ends at 19.12.17

(Vom Mitglied beendet)

Stopped prediction by melinda for InVivo Therapeutics Holdings

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€7.59
01.04.22
€12.50
01.04.23
-76.56%
04.03.23

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€8,963.6
04.02.18
€11,670
08.03.18
67.91%
08.03.18

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35,625
31.07.17
€45,000
19.12.17
-53.52%
19.12.17

Could be worthwhile Investment >10% per year